Community curated by people like you

Drug labeling & regulation stories

Oct 27, 2026

FDA warns Amgen over misleading Vectibix cancer drug promotional video

The US FDA warned Amgen that a promotional video for its colorectal cancer drug Vectibix was misleading because it highlighted benefits while failing to adequately disclose serious safety risks and patient limitations. The warning letter was issued on Tuesday.

Oct 27, 2026·2 sources

00

Top claims

▪New fraudulent cancer product companies tend to spring up as soon as one company is shut down, partially due to the ease of creating new websites.
▪The products subject to FDA warning letters were marketed to treat or cure cancer despite not having been approved as safe and effective by the FDA.
▪Fraudulent cancer products could prevent a person from seeking an appropriate and potentially life-saving cancer diagnosis or treatment.

Subtopics

Cancer & Oncology1 Drug safety1 FDA regulation1 Federal agencies1 Pharmaceutical Industry1 Pharmaceutical marketing1 Regulatory enforcement1

Related timelines

Congress

Crypto hacks

Trump administration

Venture capital funding

Iran War